C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). (Q38819669)
Jump to navigation
Jump to search
scientific article published on 16 September 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). |
scientific article published on 16 September 2016 |
Statements
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) (English)
Kai-Uwe Eckardt
Patrick Parfrey
Andrew S Levey
Brian Claggett
Marc A Pfeffer
Finnian R Mc Causland
Reshma Kewalramani
Ajay K Singh
16 September 2016
1 reference
1 reference
1 reference